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Abstract
Picornaviruses cause several diseases, not only in humans but also in various animal hosts. For
instance, human enteroviruses can cause hand-foot-and-mouth disease, herpangina, myocarditis,
acute flaccid paralysis, acute hemorrhagic conjunctivitis, severe neurological complications,
including brainstem encephalitis, meningitis and poliomyelitis, and even death. The interaction
between the virus and the host is important for viral replication, virulence and pathogenicity. This
article reviews studies of the functions of viral and host factors that are involved in the life cycle of
picornavirus. The interactions of viral capsid proteins with host cell receptors is discussed first, and
the mechanisms by which the viral and host cell factors are involved in viral replication, viral
translation and the switch from translation to RNA replication are then addressed. Understanding
how cellular proteins interact with viral RNA or viral proteins, as well as the roles of each in viral
infection, will provide insights for the design of novel antiviral agents based on these interactions.
Introduction
Picornaviruses are a large family of animal viruses, which
are pervasive in nature. Certain members of this family are
well known since they importantly affect human health.
The family Picornaviridae consists of five genera - enterovi-
ruses, rhinoviruses, cardioviruses, aphthoviruses, and
hepatoviruses. Picornaviruses are small icosahedral parti-
cles containing a single-stranded plus sense RNA genome
with approximately 7,500 nt in length. It contains a 3'
poly(A) tail with a variable length from 65 to 100 nt. The
viron RNA has a virus-encoded peptide, VPg, attached at
its 5' terminus, but this protein is rapidly lost in the cell
and most of the viral transcripts consequently lack it [1,2].
The picornavirus RNAs lack the cap structure (m7GpppN,
where m is a methyl group and N is any nucleotide). The
viral RNA encodes a single large polyprotein which under-
goes a series of processing events, mediated by virus-
encoded protease, to produce the mature virus proteins
(including 11 mature proteins plus numerous partially
processed products, depending on the virus). Four of
these proteins (VP1-VP4) constitute the virus capsid, and
the others participate in virus replication [3] (Fig. 1).
The infection of cells by enterovirus is an efficient and
productive event. To complete the life cycle of the virus,
viral proteins are involved in viral replication and transla-
tion, in addition to altering host functions, such as cellu-
lar gene expression, protein localization, signal
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transduction and membrane rearrangement. This review
focuses on the functions of viral and host factors involved
in the life cycle of picornaviruses.
Host factors and capsid proteins involved in receptor 
binding
The capsid proteins of picornaviruses are encoded by the
P1 region of the genome, and the capsid particles com-
prise 60 copies of four P1-encoded polypeptides, VP1 to
VP4. The first three viral proteins (VP1-VP3) reside on the
outer surface of the virus, and the shorter VP4 is located
completely on the inner surface of the capsids. The capsid
proteins mediate the initiation of infection by binding to
a receptor on the host membrane. Many picornaviruses
have similar receptor molecules that are members of the
immunoglobulin superfamily (IgSF), whose extracellular
regions comprise two to five amino-terminal immu-
noglobulin-like domains. For example, poliovirus recep-
tor (PVR, CD155) contains three amino-terminal
domains [4]. Additionally, coxsackievirus B1-B6 receptors
(coxsackievirus-adenovirus receptor, CAR) [5], and the
receptors for coxsackievirus A21 and major-group human
rhinovirus (intercellular adhesion molecule-1, ICAM-1),
have two and five amino-terminal domains, respectively
[6,7]. In all of these receptors, the amino-terminal
domain, D1, is involved in the binding with the conserved
amino acid residues of the picornavirus canyon, which
can trigger viral instability and uncoating. Therefore, a sin-
gle receptor suffices for virus entry, especially for poliovi-
rus and rhinovirus [8]. However, some viruses can use
non-IgSF cell surface receptors that bind to the outside of
the canyon. For example, the low-density lipoprotein
receptor (LDL-R) is used by the minor-group of rhinovi-
ruses [9], and the decay-accelerating factor (DAF or
CD55) binds to some echoviruses and group B coxsackie-
viruses [5,10]. Human P-selectin glycoprotein ligand-1
and scavenger receptor B2 are cellular receptor for entero-
virus 71 [11,12]. Furthermore, foot-and-mouth disease
viruses can attach to integrin αvβ3 or heparin sulfate, as
determined by the cell lines and the virus isolates [13,14].
These interactions, however, do not cause viral instability
or uncoating, but probably result in the aggregation of
other receptors, or trigger the subsequent endocytosis. For
example, coxsackievirus B3 (CVB3) recruits CAR to the
site of infection by binding to a second receptor DAF that
is expressed in the epithelial cells [5]. Also, coxsackievirus
A21 binds DAF for entry into cells only in the presence of
a coreceptor, ICAM-1 [6]. Indeed, receptor recognition is
important in determining the tropism of the cell and host
range. However, the interaction of capsid proteins with
intracellular host factors is also significant. For example,
VP2 of CVB3, but not VP2 of other picornaviruses, may
specifically bind to proapoptotic protein Siva, and affect
the induction of apoptosis, viral spread, and the patholog-
ical process of CVB3-caused disease [15]. As will be dis-
cussed below, factors other than virus-receptor
interaction, including cellular factors (such as polypyrimi-
dine tract-binding protein, PTB) and viral genome ele-
ments (such as internal ribosome entry site, IRES), both
interact with the 5' untranslated region (5' UTR) and thus
influence the efficiency of translation initiation and virus
replication.
Schematic of the enterovirus genome, the polyprotein products and their major functions Figure 1
Schematic of the enterovirus genome, the polyprotein products and their major functions. A diagrammatic repre-
sentation of the enterovirus genome is shown. The 11 mature polypeptides are shown, together with the three main cleavage 
intermediates. The main biological functions are included for each polypeptide. UTR, untranslated region; IRES, internal ribos-
ome entry site; VPg, viral protein genome-linked.Journal of Biomedical Science 2009, 16:103 http://www.jbiomedsci.com/content/16/1/103
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Viral proteolytic activities influence cellular functions
Leader, 2A and 3C proteases (Lpro, 2Apro and 3Cpro) are
picornavirus-encoded proteases, and are important for
viral polyprotein processing [16-18]. Lpro is present only
in aphtovirus and cardiovirus-infected cells. Viral pro-
teases not only cleave viral polypeptides, but also inhibit
various host machineries.
Picornaviral 3Cpro can reportedly enter nuclei through its
precursor 3CD' or 3CD, which contains a nuclear localiza-
tion sequence (NLS) [19,20]. 3Cpro can cleave numerous
factors and regulators that are associated with cellular
DNA-dependant RNA polymerase I, II and III, such as
TATA-box binding protein (TBP), octamer-binding pro-
tein (OCT-1), transcription activator p53, cyclic AMP-
responsive element binding protein (CREB), histone H3
and DNA polymerase III [21-26]. 3Cpro may be involved
in the virus-induced blockage of host transcription. 2Apro
reportedly cleaves TBP in-vitro, but cannot inhibit cellular
transcription [27].
2Apro and Lpro cleave eIF4GI and eIF4GII, 3Cpro cleaves
eIF4AI, which lead to the shut off of host translation [28-
32]. The cleavages of Poly(A) binding protein (PABP) by
2Apro and 3Cpro also contributes to the inhibition of cellu-
lar translation [33,34]. Furthermore, EMCV 2A protein
without a catalytic function reportedly associates with 40S
ribosome subunit, suggesting another mechanism of host
translation shut off [35].
Numerous cytoskeleton-associated factors are cleaved in
virus infection. 3Cpro cleaves microtubulin-associated pro-
tein 4 and 2Apro cleaves cytokeratin 8, which may be asso-
ciated with the virus-induced cytopathic effect [36,37].
2Apro of enteroviruses, such as the coxsackievirus B group
cleaves dystrophin protein, which may be the factor lead-
ing to cardiomyopathy [38-40]. Additionally, 2Apro and
3Cpro reportedly induce cell apoptosis via both classic and
autophagy pathways [41-44].
Infection by poliovirus and rhinovirus involves accumula-
tion of nuclear proteins in cytoplasm. Several compo-
nents of the nuclear pore complex were degraded in
infected cells and 2Apro has been suggested to be a factor
that blocks nucleo-cytoplasmic trafficking [45-48].
Viral and host proteins involved in RNA replication
Picornavirus infection induces a change in host mem-
brane permeability and the production of membranous
structures, on which viral replication depends [49-52].
The viral replication complex has been identified to asso-
ciate tightly with virus-induced membranous vesicle [53],
various replication-associated viral proteins, such as 2B,
2BC, 3A, and 3D [52,54,55] and host proteins (Table 1).
2B/2BC
Viral protein 2B and its precursor 2BC have been sug-
gested to be responsible for membranous alteration in
infected cells [56-60]. The cellular proteins of COPII have
reportedly been used in the virus-induced production of
vesicles [61]. 2B and the precursor 2BC contain two
hydrophobic regions, which are α amphipathic a-helix
domain, which is important in multimerization, integrat-
ing into the membrane of the host Golgi and ER complex,
producing virus-induced vesicles, and forming the vir-
porin complex [60,62-64]. The accumulation of 2B or
2BC proteins on Golgi changes the permeability of
plasma membrane [56,62] and the disassembly of Golgi
complex [65], causing cell lysis [57]. The membrane that
integrates the 2B/2BC complex also reduces the Ca2+ level
in ER and Golgi complex by increasing the efflux of Ca2+
[57]. The disruption of Ca2+ homeostasis by 2B/2BC is the
mechanism why the transport of protein from ER to Golgi
is blocked [58,59,66,67]. The 2B-induced intracellular
Ca2+ imbalance is also related to the anti-apoptosis prop-
erty [68]. Hepatitis A virus 2B protein can reportedly
inhibit cellular IFN-β gene transcription by blocking the
activation of the interferon regulatory factor 3 (IRF-3),
Table 1: Cellular proteins involved in picornaviral RNA replication
Proteins Binding sites/associated viral proteins Viruses Refs
PCBP1 Cloverleaf PV [93,95]
PCBP2 Cloverleaf, 3CD, 3C PV [92,93,106]
hnRNP C Negative strand 3' stem-loop I, 3D, 3CD, P2, P3 PV [97]
hnRNP K 5' UTR EV71 [96]
Sam68 3D PV, CVB3 [105,169]
PABP 3CD, stem-loop I and poly(A) tail PV [106,107]
OCT-1 3CD, 3C PV, HRV16 [19,23]
B23 3CD HRV16 [19]
La 3' and 5' UTR CVB3 [112]
EF-1α 3CD, stem-loop I PV [91]
*PCBP, poly(rC) binding protein; hnRNP, heterogeneous nuclear ribonucleoprotein; PABP, poly(A)-binding protein; La, Lupus autoantigen; EF-1α, 
eukaryotic elongation factor 1 alpha.Journal of Biomedical Science 2009, 16:103 http://www.jbiomedsci.com/content/16/1/103
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which has been suggested to be crucial to the survival of
the virus [69].
3A
Protein 3A, a membrane binding protein, plays a role in
inhibiting cellular protein secretion and mediating pres-
entation of membrane proteins during viral infection. The
expression of poliovirus 3A protein in cells disrupts ER-to-
Golgi trafficking, which is also observed in poliovirus 2B-
expressing cells [58,65,70]. Moreover, the interference of
protein trafficking by 3A is caused by the redistribution of
ADP-ribosylation factor (Arf) family, which are important
components of the membrane secretion pathway [71].
The cycling of Arf proteins between active GTP-bound and
inactive GDP-bound forms are mediated by guanine
nucleotide exchange factors (GEFs) and Arf GTPase-acti-
vating proteins (GAPs) [72]. Brefeldin A (BFA), a metabo-
lite from fungus, blocks protein trafficking from ER to
Golgi in cells by inhibiting the regeneration of Arf-GTP
from Arf-GDP [73]. BFA can also inhibit the replication of
poliovirus, implying the participation of Arf proteins in
viral RNA replication [74-76]. During poliovirus infec-
tion, the Arf family is involved in vesicle formation from
various intracellular sites through interacting with numer-
ous regulatory and coat proteins, and translocating to the
site of viral RNA replication [71]. Two individual viral
proteins, 3A and 3CD, can recruit Arfs to bind to mem-
branes via different mechanisms [77,78]. The expression
of 3A results in the recruitment of Arfs to membranes by
specifically recruiting the cellular GEF, and Golgi-specific
brefeldin A resistance factor 1 (GBF1). However, synthesis
of 3CD causes other GEFs, Brefeldin A-inhibited guanine
nucleotide exchange factor 1 (BIG1) and BIG2, to associ-
ate with membranes [77].
3AB
According to biochemical data, the 3AB protein is a mul-
tifunctional protein. The hydrophobic domain in the 3A
portion of the protein associates with membrane vesicles
[79,80]. This interaction is believed to anchor the replica-
tion complex to the virus-induced vesicles. Recombinant
3AB interacts with poliovirus 3D and 3CD in vitro [81].
The membrane-associated 3AB protein binds directly to
the polymerase precursor 3CD on the cloverleaf RNA of
the poliovirus, stimulating the protease activity of the
3CD, and may serve as an anchor for 3D polymerase in
the RNA replication complexes [82]. Adding 3AB stimu-
lated the activity of poliovirus 3D polymerase in vitro [83].
Furthermore, 3AB has been demonstrated to function as a
substrate for 3D polymerase in VPg uridylylation [84].
The 3AB protein, rather than 3B (the mature VPg), has
been proposed to be delivered to the replication com-
plexes for VPg uridylylation. Poliovirus 3AB exhibits other
functions, such as helix destabilization, revealing that 3AB
has the nucleic acid chaperon activity in destabilizing the
secondary structures of RNA and enhancing the hybridiza-
tion in complementary nucleic acids in viral replication
[85].
3B
The enteroviral and rhinoviral 3B proteins (VPg) are small
peptides, containing 21 to 23 amino acids, which are cov-
alently linked with the 5' termini of picornavirus genome
via a 5' tyrosyluridine bond in the conserved tyrosine res-
idue in the VPg. VPg has been shown to interact with
poliovirus 3D polymerase, which incorporates UMP in
VPg, yielding VPgpU and VPgpUpU [86]. These products
are observed in both poliovirus-infected cells and crude
replication complex extract [87]. The uridylylated VPg is
utilized as a primer in both positive- and negative-strand
RNA synthesis [88].
3CD
3CD protein, i.e. the precursor of mature 3C protease and
3D polymerase, exhibits protease activity but no polymer-
ase activity [89]. 3CD is capable of processing the poliovi-
rus P1 precursor region [90]. Poliovirus 3CD contributes
to viral RNAreplication by circularization of the viral
genome via interacting with both 5' and 3' ends of viral
RNA [91]. The cellular poly(rC) binding proteins
(PCBPs), involved in viral IRES-driven translation, is also
identified in the ribonucleoprotein complex, which con-
tains 3CD and have a stem-loop I structure at the 5' end of
the poliovirus genome [92,93]. PCBPs contain four iso-
forms (PCBP 1-4) in mammalian cells, but only PCBP1
and 2 have been found to be involved in enterovirus rep-
lication [92,93]. PCBP1 and 2 are KH domains RNA-bind-
ing proteins, which are involved in the metabolism of
cellular mRNAs in normal cells. PCBP2 binds to both
poliovirus stem-loop I and IRES, whereas PCBP1 has a
binding affinity only for stem-loop I [94,95]. The addition
of recombinant PCBP1 rescues viral RNA replication in
PCBP-depleted extracts, but does not rescue viral transla-
tion [95]. Another cellular protein, heterogeneous nuclear
ribonucleoprotein K (hnRNP K), interacts with stem-
loops I-II and IV of the EV71 5' UTR. During EV71 infec-
tion, hnRNP K was enriched in the cytoplasm where virus
replication occurs, whereas hnRNP K was localized in the
nucleus in mock-infected cells. Viral yields were found to
be significantly lower in hnRNP K knockdown cells and
viral RNA synthesis was delayed in hnRNP K knockdown
cells in comparison with negative-control cells treated
with small interfering RNA [96]. Moreover, 3CD has been
shown, using the pull-down assay, to interact with heter-
ogeneous nuclear ribonucleoprotein C (hnRNP C) [97].
The hnRNP C participates in pre-mRNA processing in nor-
mal cells. The mutant form of hnRNP C with the defective
activity in protein-protein interaction inhibits the synthe-
sis of viral positive-strand RNA, implying the participa-
tion of hnRNP C in RNA replication [97]. The interactionsJournal of Biomedical Science 2009, 16:103 http://www.jbiomedsci.com/content/16/1/103
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of 3CD with these cellular proteins, PCBP, hnRNP C and
the viral protein, 3AB, together with the stem-loop I struc-
ture of poliovirus, form important complexes in viral RNA
replication [98]. Several other cellular proteins have been
reported to interact with 3CD. For example, the eukaryotic
elongation factor EF-1α, one such cellular cofactor, can
interact with the poliovirus 3CD-stem-loop I complex
[91]. The transcription factor OCT-1 and the nucleolar
chaperone B23, have also been identified as co-localizing
in nuclei with HRV-16 3CD during virus infection [19].
Additionally, the recombinant mature HRV-16 3C can
cleave OCT-1 in vitro. The mature 3C from the precursor
3CD may play a role in shutting off host cell transcription
in nuclei. As well as exhibiting protease activity, 3CD
interacts with viral RNA structures, the stem-loop I, 3' UTR
and the cis-acting replication element (cre) motif of polio-
virus RNA, which is the template for VPg uridylylation
[91-93,99,100].
3D
The viral RNA-dependent RNA polymerase 3D is one of
the major components of the viral RNA replication com-
plex. The purified poliovirus 3D polymerase from the
complex exhibits elongation activity [101]. 3D polymer-
ase can also uridylylate VPg and use VPg-pUpU as a
primer during viral RNA replication [86,102]. The
polymerase-polymerase interaction of poliovirus has
been observed in biochemical and crystal structure studies
[81,103,104]. The polymerase oligomerization has been
proposed to be responsible for efficient template utiliza-
tion. The host protein, Sam68, was identified as interact-
ing with poliovirus 3D using a yeast-two hybrid system
[105]. This interaction has also been observed in poliovi-
rus-infected cells. Sam68, an RNA binding protein, medi-
ates alternative splicing in cells in response to an
extracellular signal. The details of the functions of Sam68
in virus RNA replication need to be demonstrated.
cis elements involved in RNA replication
The RNA secondary structures in the viral genome play
important roles in the replication of viral RNA. The cis ele-
ments contain stem-loop I at the 5' terminus of 5' UTR, 3'
UTR and poly(A) tail at the 3' terminus of enterovirus
RNA. The circularization of the poliovirus template
between the 5' and 3' termini of the viral genome is crucial
during the initiation of both positive and negative-strand
RNA replication [106,107]. The 3CD and PCBP2 on stem-
loop I at the 5' terminus of 5' UTR and poly(A)-binding
protein (PABP) and 3CD on the 3' termini of genome are
involved in the circularization of RNA genome for initia-
tion of negative-strand RNA synthesis [106]. The enterovi-
rus 3' UTR serves as the initiation point of negative-strand
RNA synthesis. The 3CD or 3D has the ability for the inter-
action with the 3' UTR element [91]. The binding of 3CD
and 3AB to 3' UTR does not depend on the interaction
with host proteins and suffices for viral RNA replication in
vitro [91]. Moreover, many works have reported that host
proteins can bind to the 3' UTR of rhinovirus and entero-
virus [91,108,109]. Nucleolin, a nuclear factor, which
accumulated in the cytoplasm of poliovirus-infected cells,
interacted strongly with an intact 3'-UTR of poliovirus in
vitro [110]. The immunodepletion of nucleolin from cell-
free extract reduced virus reproduction, indicating that
nucleolin may be involved in viral RNA replication. The 3'
stem-loop I of the negative-strand RNA is the initiation
site of positive-strand RNA synthesis. Positive-strand RNA
synthesis is initiated by the recruitment of uridylylated
VPg-containing replication complexes close to the 3' stem-
loop I of the negative strand. Viral protein 2C has been
reported to interact directly with the 3' stem-loop I of the
negative strand [111]. The cellular protein, hnRNP C,
which specifically interacts with either the 3' end of the
poliovirus negative-strand RNA or the protein 3CD, is
involved in positive-strand RNA synthesis, and probably
in the initiation step [97]. Some cellular proteins, such as
La, can interact with both 3' and 5' UTRs of CVB3 inde-
pendently of the poly(A) tail, and may play a role in medi-
ating cross-talk between the 5' and 3' ends of CVB3 RNA
for viral RNA replication [112].
Synthesis of the uridylylated VPg is the first step of viral
RNA synthesis. The efficient uridylylation of VPg requires
3D polymerase, 3CD protein, UTP and the cre motif from
the viral genome as the template. 3CD has been shown to
stimulate cre-mediated VPg uridylylation [102]. Moreo-
ver, the 3AB protein is regarded as the precursor of VPg
(3B) in the RNA replication complex for VPg uridylylation
[84]. The cre motif was identified in different regions of
the enterovirus genome. The cre structures are located in
the 2C-encoding region of poliovirus, the capsid-encod-
ing region of human rhinovirus 14 and cardiovirus, the
2A-encoding region of human rhinovirus 2, the 5' non-
coding region of the foot-and-mouth disease virus, and
the 3D-encoding region of the hepatitis A virus [113-118].
Switch from translation to RNA replication
The positive-stranded RNA viruses use the same RNA as a
template for translation and replication. Ribosomes move
from the 5' end to the 3' end of RNA to undergo transla-
tion, and RNA polymerase binds to the 3' end of the same
RNA to initiate replication. In vitro experiments have dem-
onstrated that using cycloheximide to freeze ribosomes
on translated RNAs inhibits RNA replication, while using
puromycin to release the ribosomes allows facilitates RNA
replication [119]. These two events cannot occur at the
same time, so the balance between translation and repli-
cation is important.
The poliovirus genome contains a conserved 5' UTR,
which is important to translation and RNA replicationJournal of Biomedical Science 2009, 16:103 http://www.jbiomedsci.com/content/16/1/103
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[120]. Gamarnik and Andino have suggested that the
binding of 3CD to the cloverleaf at the 5' end of the viral
genome promotes the replication of RNA, rather than its
translation [121]. Furthermore, they found that PCBP2
binds to stem-loop IV in poliovirus translation. When
newly translated 3CD binds to stem-loop I RNA, the affin-
ity of PCBP2 binding for the same region is increased.
3CD induces the dissociation of PCBP2 from stem-loop
IV because the affinity of PCBP2 for stem-loop I is
increased, while that for viral translation is reduced [98].
Semler et al. found that proteases 3C/3CD cleave PCBP1
and 2 during the mid-to-late phase of poliovirus infec-
tion. The primary cleavage site is between the KH2 and
KH3 domains. The cleaved PCBP2 cannot bind to stem-
loop IV and it loses functionality in translation. However,
the cleaved PCBP2 still binds to stem-loop I and mediates
the replication of viral RNA. PCBP2 can mediate the
switch from viral translation to RNA replication [122].
Host factors and viral proteins involved in picornaviral 
IRES-mediated translation
Most picornaviral IRESs are divided into four classifica-
tions based on homology, secondary structure, and other
properties (Fig. 2). Type I IRESs include those of poliovi-
rus, rhinovirus, coxsackievirus, and other enteroviruses.
Type II IRESs include those of the foot and mouth disease
virus (FMDV), cardiviruses such as encephalomyocarditis
virus (EMCV), paraechoviruses and kobuvirus. Type III
IRESs include the hepatitis A virus (HAV). The newly clas-
sified teschovirus IRES is the most similar to hepatitis C
virus, which is not a picornavirus, and so may represent an
ancient recombinant event between an enterovirus and
hepacivirus or pestivirus [123].
IRES-mediated initiation may require both canonical ini-
tiation factors and IRES trans-activating factors (ITAFs)
that are not involved in cap-mediated initiation. ITAFs are
cellular proteins that are not involved in normal cap-
dependent translation but facilitate cap-independent
translation. Different viral IRESs have different ITAF
requirements, although several are shared. ITAFs may
serve as IRES chaperones, binding to RNA across multiple
domains and stabilizing the entire IRES in a configuration
that is appropriate for binding canonical translation fac-
tors, and ultimately ribosomes (Table 2) [124].
Canonical translation factors
PV and EMCV IRES elements are similar to capped mRNA
in requiring that some initiation factors bind to primed
40S subunits and to the RNA itself. These canonical fac-
tors have been identified as eIF4G and eIF4B, which bind
to the viral RNA, and eIF3 and eIF2, which must prebind
the 40S subunit. Furthermore, poly(A)-binding protein
substantially promotes the IRES-mediated translation of
EMCV and PV. This rather high requirement of picornavi-
Structural features of type I, II, III, and IV picornavirus IRES elements Figure 2
Structural features of type I, II, III, and IV picornavirus IRES elements. RNA secondary structures of four types base 
on M-fold software. (A). Enteroviruses (PV, CVB3 and EV71) and rhinoviruses contain type I IRES elements. (B). Aphthoviruses 
(FMDV) and cardiovirus (EMCV and TMEV) contain type II IRES elements. (C). HAV contains type III IRES element. (D). por-
cine reschovirus serotype 1 (PTV-1) contains type IV IRES element.Journal of Biomedical Science 2009, 16:103 http://www.jbiomedsci.com/content/16/1/103
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ral IRESs for canonical translation factors is in contrast to
that of IRES elements of other viruses, such as hepatitis C
virus and the cricket paralysis virus, which require few or
no translation factor to bind to the ribosome [125].
Noncanonical translation factors
Polypyrimidine tract-binding protein (PTB)
PTB (also known as p57 and hnRNP I) is a member of the
hnRNP family and shuttles between the nucleus and the
cytoplasm in a transcription-sensitive manner [126]. PTB
is a 57 kDa mRNA splicing factor and has four RNA recog-
nition motifs (RRMs). PTB was identified originally as a
protein that binds to the polypyrimidine tracts (Py tracts)
of adenoviral major-late and α-tropomyosin pre-mRNAs,
and has been proposed to be a splicing factor [127]. The
binding of PTB to the Py tract close to the branching point
of intron has been demonstrated to modulate the alterna-
tive splicing of certain pre-mRNAs [128]. Independently,
PTB was shown to interact specifically with the IRESs of
numerous picornaviruses [129,130], including poliovirus
[131,132], FMDV [133], EMCV [134], Theiler's murine
encephalomyelitis virus (TMEV) [135], and HAV
[136,137].
Experiments on the depletion and repletion of PTB from
rabbit reticulocyte lysate (RRL) have revealed that the effi-
cient translation of FMDV mRNA and a mutant EMCV
mRNA depends on PTB [133,134]. Intriguingly, PTB is
required for the translation of a mutant EMCV mRNA, but
not wild-type EMCV [138], suggesting that PTB is
involved in maintaining the proper conformation of the
mutant EMCV IRES [138]. Supplementation of RRL with
PTB enhances the translation of polioviral mRNA
[139,140]. The immunodepletion of PTB from HeLa cell
lysate inhibited poliovirus IRES-dependent translation.
Repletion of purified PTB to the immunodepleted lysate
did not restore poliovirus IRES-dependent translation.
This investigation suggested that the depletion process
may have removed unidentified translation factors [132].
The effect of PTB on poliovirus IRES-dependent transla-
tion was examined using artificial dicistronic mRNAs that
contain the PTB gene as the first cistron, the poliovirus
IRES in the intercistronic region, and the chlorampheni-
col acetyltransferase (CAT) reporter gene as the second cis-
tron. When PTB was transfected into HeLa cells, which
contain a limited amount of endogenous PTB, its addi-
tional expression increased the activity of poliovirus IRES
by 2.5-fold [141]. These results suggest that PTB is
required for, or at least promotes, the IRES activity of
picornavirus.
Poliovirus protein, 3Cpro (and/or 3CDpro), cleaves PTB
isoforms (PTB1, PTB2, and PTB4). PTBs contain three
3Cpro target sites (one major target site and two minor tar-
get sites). PTB fragments that are produced by PV infection
are redistributed to the cytoplasm from the nucleus,
where most of the intact PTBs are localized. Additionally,
these PTB fragments inhibit poliovirus IRES-dependent
translation in a cell-based assay system. The authors posit
that the proteolytic cleavage of PTBs may contribute to the
molecular switching from translation to the replication of
polioviral RNA [142].
PV-attenuated type 3 Sabin and virulent type 3 Leon
viruses translated equally well in HeLa cells, but the trans-
lation of the attenuated Sabin virus is restricted in neurob-
lastoma cells. The C472-to-U mutation in the IRES caused
the translation defect. Comparison of IRES between Leon
serotype 3 and Sabin serotype 3 PV revealed that PTB and
a novel neural-cell-specific homologue of PTB (nPTB)
Table 2: Cellular proteins involved in picornaviral IRES-mediated translation
Proteins Binding sites/associated viral proteins Viruses Refs
PTB IRES, 3C PV, HRV, EMCV, FMDV, TMEV, HAV [130-136]
nPTB IRES PV, TMEV [135,143]
PCBP1 Cloverleaf, IRES PV, HRV [93,153]
PCBP2 Cloverleaf, IRES, 2A, 3CD, 3C PV, HRV, HAV, CVB3 [94,152-154,156,170]
Unr IRES PV, HRV [139,157]
La IRES, 3C PV, HRV, HAV, CVB3, EMCV [147,148,150,151,171]
ITAF45 IRES FMDV [124]
hnRNP A1 IRES HRV2, EV71 [158,159]
Nucleolin/C23 IRES PV, HRV [162]
DRBP 76: NF45 heterodimer IRES HRV2 [163,164]
GAPDH IRES HAV [137,172]
FBP2 IRES EV71 [168]
PABP IRES PV, EMCV [125,173]
*PTB, polypyrimidine tract-binding protein; nPTB, neural polypyrimidine tract-binding protein; PCBP, poly(rC) binding protein; Unr, upstream 
element binding protein; La, Lupus autoantigen; hnRNP, heterogeneous nuclear ribonucleoprotein; DRBP 76: NF45 heterdimer, dsRNA binding 
protein 76: NF45 heterdimer; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; FBP2, far upstream element binding protein 2; PABP, poly(A)-
binding protein.Journal of Biomedical Science 2009, 16:103 http://www.jbiomedsci.com/content/16/1/103
Page 8 of 14
(page number not for citation purposes)
were bound adjacent to the attenuation mutation in
domain V, but binding was less efficient on the Sabin
IRES. The Sabin IRES was demonstrated to have a transla-
tion defect in chicken neurons that can be rescued by
increased PTB expression in the CNS [143].
PTB has also been shown most clearly to function as an
RNA chaperon, stabilizing the type II IRESs, such as EMCV
and FMDV, in an active conformation [144,145].
Lupus autoantigen (La)
Lupus autoantigen (La) is a 52 kDa, predominantly
nuclear protein. It is a target for autoimmune recognition
in patients with systemic lupus erythematosus and
Sjogren's syndrome. The majority of La is localized in the
nucleus, and it is related to stabilization of nascent RNAs,
nuclear retention of nascent transcripts, and RNA pol III
transcription termination. During PV infection, La is
redistributed to the cytoplasm by 3 h postinfection (p.i.)
[146,147]. This redistribution coincides with the appear-
ance of 3Cpro in infected cells, and is caused by a 3Cpro-
mediated cleavage event, which removes a nuclear locali-
zation signal from the C-terminus of La, but maintains the
dimerization domain. The truncated La can still stimulate
translation effectively, but is relocalized to the cytoplasm
during viral protein synthesis [147]. Depletion of La from
cells by small interfering RNA reduced IRES translation.
Similarity, a dominant-negative mutant of La inhibited
40S ribosomal binding by PV IRES in vitro [148]. La pro-
tein also binds to the CVB3 IRES and stimulates viral
translation in a dose-dependent manner in rabbit reticu-
locyte [149,150]. La protein binds specifically to distinct
parts of HAV IRES, and suppresses HAV IRES-mediated
translation and replication by small interfering RNA in
vivo and purified La protein in vitro [151].
Poly(rC)-binding protein 1, 2 (PCBP1, 2)
PCBPs are RNA-binding proteins that preferentially bind
to single-stranded stretches of cytidines. Mammalian cells
contain four isoforms, PCBP 1-4, but only PCBP1 and
PCBP2 have been experimentally demonstrated to have
roles in the life cycles of enteroviruses [93]. PCBP2 is a fac-
tor that is required for poliovirus translation and was dis-
covered because of its interaction with stem-loop IV of the
poliovirus IRES [94]. Depletion and replication studies of
PCBP2 from HeLa cell-free extracts using a stem-loop RNA
affinity column have revealed that PCBP2 was required
for PV IRES-dependent translation [152]. Moreover, an
oligo-DNA with high affinity to PCBP1 and PCBP2 was
recently used to prove that both PCBP1 and PCBP2 func-
tion as ITAFs of the PV IRES [153]. PCBP2 also binds to
the HAV 5' UTR and stimulates viral translation [154].
One nucleocytoplasmic SR protein, SRp20, interacts with
PCBP2 and is involved in the internal ribosome entry site-
mediated translation of viral RNA. Both depletion and in
vitro  translation studies of SRp20 from HeLa cell free
extracts have shown that SRp20 is required for the initia-
tion of PV translation. Targeting SRp20 in HeLa cells with
short interfering RNAs inhibited the expression of SRp20
protein and correspondingly reduced PV translation
[155].
In vitro translation reactions were performed in HeLa cell
cytoplasmic translation extracts whose cellular protein,
PCBP2 was depleted [156]. Upon depletion of PCBP2,
these extracts exhibited a significantly reduced capacity to
translate reporter RNAs that contained the type I IRES ele-
ments of poliovirus, coxsackievirus, or human rhinovirus,
which is linked to luciferase; however, adding recom-
binant PCBP2 protein restored translation. RNA electro-
phoretic mobility-shift analysis demonstrated specific
interactions between PCBP2 and both type I and type II
picornavirus IRES elements; however, the translation of
reporter RNAs that contain the type II IRES elements of
the encephalomyocarditis virus and the foot-and-mouth
disease virus did not depend on PCBP2. These data indi-
cate that PCBP2 is essential for the internal initiation of
translation on picornavirus type I IRES elements, but not
by the structurally distinct type II elements [156].
Upstream of N-ras (Unr)
Upstream of N-ras (Unr) is a cytoplasmic protein that
contains five cold-shock domains. A depletion study of
Unr from reticulocyte lysate revealed that Unr was
required for the translation of rhinovirus IRES [139]. Both
HRV and PV IRES translation was severely impaired in
unr(-/-) murine embryonic stem cells. Translation was
restored by the transient expression of Unr in unr(-/-) cells
[157].
Heterogenerous nuclear ribonucleoprotein A1 (hnRNP A1)
hnRNP A1, an RNA-binding protein that shuttles between
the nucleus and the cytoplasm, is a member of a large
group of RNA binding proteins (hnRNPs) which are clas-
sified into several families and subfamilies based on con-
served structural and functional motifs. The hnRNP A1
protein is composed of 320 amino acids; it contains two
RNA-binding domains and a glycine-rich domain, which
is responsible for protein-protein interaction.
hnRNP A1 is an internal ribosome entry site (IRES) trans-
acting factor that binds specifically to the 5' UTR of the
HRV2 and regulates its translation. Furthermore, the cyto-
plasmic redistribution of hnRNP A1 after rhinovirus infec-
tion enhances rhinovirus IRES-mediated translation
[158]. RNA-protein pull down assay, reporter assay and
viral RNA synthesis assay reveal that hnRNP A1 also inter-
acts with the 5' UTR of enterovirus 71 (EV71) and regu-
lates viral replication [159].Journal of Biomedical Science 2009, 16:103 http://www.jbiomedsci.com/content/16/1/103
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ITAF45
ITAF45 is also known as erbB3-binding protein 1 (Ebp1)
or p38-2G4, which is a proliferation-dependent protein
that is distributed throughout the cytoplasm from the
metaphase to the telophase. ITAF45 is a proliferation-
dependent protein that is undetectable in murine brain
cells and so may function as a tissue-specific factor that
controls the translation of particular mRNAs. The initia-
tion on the TMEV IRES depended strongly on PTB, where
the initiation on the FMDV IRES depended on both PTB
and ITAF45. ITAF45 was bound specifically to a central
domain of the FMDV IRES and acted synergistically with
PTB to promote the binding of eIF4F to an adjacent
domain [124].
Nucleolin/C23
As a 110 kDa nucleolar protein, nucleolin/C23 protein is
also an RNA binding protein which contains four RNA
binding motifs [160]. Nucleolin is an abundant protein of
the nucleolus and participates in rDNA transcription,
rRNA maturation, ribosome assembly and nucleocyto-
plasmic transport [161]. Nucleolin/C23 has been shown
to translocate into the cytoplasm following the infection
of cells with PV [110]. Nucleolin/C23 stimulates PV IRES-
mediated translation in vitro and rhinovirus IRES-medi-
ated translation in vivo. Nucleolin/C23 mutants that con-
tain the carboxy-terminal RNA binding domains, but lack
the amino-terminal domains, act as dominant-negative
mutants in in vitro translation assay. The translation inhib-
itory activity of these mutants is related to their capacity to
bind to the 5' UTR sequence [162].
dsRNA binding protein76:NF45 heterodimer
The double-stranded RNA binding protein 76 (DRBP76)
contains two dsRNA-binding motifs and is almost identi-
cal to M-phase phosphoprotein 4, NF90, translation con-
trol protein (TCP80), and NF associated with dsRNA.
DRBP76 has been found to bind to the HRV2 IRES in neu-
ronal cells and to inhibit PV-RIPO translation and propa-
gation [163]. The size of exclusion chromatography
indicates that DRBP76 heterodimerizes with the nuclear
factor of activated T cells, of size 45 kDa (NF45), in neu-
ronal but not in glioma cells. The DRBP76:NF45 het-
erodimer binds to the HRV2 IRES in neuronal but not in
glioma cells. Ribosomal profile analyses have demon-
strated that the heterodimer preferentially associates with
the translation apparatus in neuronal cells, and arrests
translation at the HRV2 IRES, preventing the assembly PV-
RIPO RNA into the polysome [164].
Far upstream element binding protein 2 (FBP2)
The far upstream element binding protein 2 (FBP2) is also
known as the K homology (KH)-type splicing regulatory
protein (KSRP). It was originally identified as a compo-
nent of a protein complex that assembles on an intronic c-
src neuronal-specific splicing enhancer, and as an impor-
tant adenosine-uridine element binding protein (ARE-BP)
that interacts with several AREs [165,166]. FBP2 is
required for the rapid decay of several ARE-containing
mRNAs both in vitro and in vivo. It contains four contigu-
ous KH motifs that recognize the ARE, interact with the
exosome, and the poly(A) ribonuclease (PARN), and pro-
mote the rapid decay of ARE-containing RNAs [167].
Biotinylated RNA-affinity chromatography and pro-
teomic approaches were utilized to identify FBP2 as an
ITAF for EV71. During EV71 infection, FBP2 was enriched
in cytoplasm where viral replication occurs, whereas FBP2
was localized in the nucleus in mock-infected cells. The
synthesis of viral proteins was promoted in FBP2-knock-
down cells that were infected by EV71. IRES activity in
FBP2-knockdown cells exceeded that in the negative con-
trol (NC) siRNA-treated cells. However, IRES activity
decreased when FBP2 was over-expressed in the cells. The
results of this investigation suggest that FBP2 is a novel
ITAF that interacts with EV71 IRES and negatively regu-
lates viral translation [168].
Compelling evidence suggests that cellular RNA-binding
proteins (ITAFs) are involved importantly in translation
from a variety of IRES elements, suggesting potential roles
for RNA-binding proteins in IRES-dependent translation.
First, an RNA-binding protein recruits the translational
machinery via a protein-protein or protein-RNA interac-
tion. This putative RNA-binding protein then binds
directly to the ribosomal subunit, to canonical translation
factors, or to a putative mediator protein that connects
other RNA-binding proteins with the basal translational
machinery. Second, RNA-binding proteins may serve as
'clamping proteins,' holding various parts of IRES RNA in
a particular configuration. Components of the transla-
tional machinery may bind exclusively to the RNA por-
tion of the RNA-protein complex that is maintained by
these clamping proteins.
Concluding remarks
Picornaviruses use multiple RNA-protein interactions to
mediate important reactions in their life cycle, including
IRES-mediated translation, possible circularization of the
genome, and RNA replication. The molecular mecha-
nisms by which host factors are involved in RNA-protein/
protein-protein interaction have been intensively studied;
however, tissue-specific viral virulence remains unclear,
and demands further investigation in the future. No infor-
mation is available on whether picornaviruses can be tar-
geted by cellular microRNAs, leading to transcriptional or
translational silencing, or RNAi-mediated degradation of
viral RNA. This is another field that needs to be further
studied in the future.Journal of Biomedical Science 2009, 16:103 http://www.jbiomedsci.com/content/16/1/103
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